{
  "url": "https://openlegislation.uk/eu-decision-2019-417/annex/division-1/part-II/division-3/division-3.4/division-3.4.3/division-3.4.3.3/division-b",
  "json_url": "https://openlegislation.uk/eu-decision-2019-417/annex/division-1/part-II/division-3/division-3.4/division-3.4.3/division-3.4.3.3/division-b.json",
  "legislation": "eudn/2019/417",
  "legislation_title": "Commission Implementing Decision (EU) 2019/417 of 8 November 2018 laying down guidelines for the management of the European Union Rapid Information System ‘RAPEX’ established under Article 12 of Directive 2001/95/EC on general product safety and its notification system (notified under document C(2018) 7334)",
  "legislation_url": "https://openlegislation.uk/eu-decision-2019-417",
  "path": "annex/division/1/part/II/division/3/division/3.4/division/3.4.3/division/3.4.3.3/division/b",
  "kind": "division",
  "number": "(b)",
  "heading": "Notifications of cosmetic products",
  "text": "Validation of notifications that do not include a detailed risk assessment may equally be possible for cosmetic products containing banned or restricted substances, which are backed up by an EU scientific committee opinion supporting that such presence of substances above the established limits poses a risk to the health and safety of consumers. For this specific product sector, other factors (e.g. concentration or time of exposure) may need to be taken into consideration.\nNevertheless, if measures have been taken against a product containing not authorised chemical substances for which no scientific opinion has been issued confirming that the product poses a risk, a proper risk assessment may be required depending on a case-by-case analysis to prove that the product poses a serious or less than serious risk. In cases where the risk assessment is needed, if such risk assessment is not provided, these cases shall only be validated ‘for information’ in RAPEX.\nAs regards products that are subject to restrictive measures by market surveillance authorities based on the presence of a chemical substance mentioned in the list of ingredients which is subject to restrictions contained in EU Legislation and where there is no scientific data assessing the risk, notifications need to be assessed on a case-by-case basis. In case where the risk assessment is needed, if such risk assessment is not provided, these cases shall only be validated ‘for information’ in RAPEX.",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eudn/2019/417/annex/division/1/part/II/division/3/division/3.4/division/3.4.3/division/3.4.3.3/division/b",
    "retrieved_at": "2026-11-01T15:12:47.956200+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}